Leveraged Finance Fights Melanoma
September 10, 2020 | 6pm ET.
The LFFM 2020 Webcast will air September 10th at 6pm EST/3pm PST with Mike Milken hosting a series of discussions and a welcome from Leon Black:
- COVID-19: Impact on Medical Research and Progress on Treatments & Vaccines with Esther Krofah, Executive Director of FasterCures, and David Feinberg, MD, VP of Google Health
- Insights and Perspectives: Markets, Private Equity and Leveraged Finance with Orlando Bravo, Founder & Managing Director, Thoma Bravo.
Please email Janine Rauscher with any questions or to sponsor.
2020 Event Chairs: Clare Bailhé (Apollo MidCap), Brendan Dillon (UBS), Kerry Dolan (PSP Investments), Lee Grinberg (Elliott Management), George Mueller (KKR), AJ Murphy (Silver Lake), Geoff Oltmans (Silver Lake), Jeff Rowbottom (Iron Park Capital), Ian Schuman (Latham & Watkins), Cade Thompson (KKR), & Trevor Watt (Hellman & Friedman)
About LFFM: Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities who come together to fight melanoma, the deadliest form of skin cancer. Some of the most prominent names in the industry —Carl Icahn, Mike Milken, Leon Black, Henry Kravis and Howard Marks—have been featured.
The annual event raises critical funds for melanoma research and awareness on skin cancer prevention. Founded in 2011 by Jeffrey Rowbottom of PSP Investments and Brendan Dillon of UBS—both of whom combatted melanoma— the LFFM event has raised more than $13 million that goes directly to research.
Advances in melanoma research supported by MRA have changed the landscape dramatically for patients, with 13 of the 15 treatment options coming to market since the event’s kick-off. These advances have created a ripple effect across the field of oncology. Drugs first approved in melanoma are now being tested in more than 30 cancers.
2020 LFFM Sponsors: